This country profile provides an overview of Madagascar’s progress in reaching those in need of mass NTD treatment based on 2019 data.
*This includes all countries in Africa that are endemic for at least one of the five NTDs
Treatment coverage was not reported in 2018 and 15% in 2019.
Madagascar does not require mass treatment for blinding trachoma.
Treatment coverage increased from 0% in 2018 to 53% in 2019.
Treatment coverage increased from 0% in 2018 to 66% in 2019.
Madagascar does not require mass treatment for river blindness.
The ESPEN portal (a World Health Organization AFRO region project) provides maps and district-level data for the preventive chemotherapy diseases in Madagascar.